Researchers, led by Dr Huiying Li, an associate professor of molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, used over-the-counter pore cleansing strips to obtain skin follicle samples from 72 individuals: 38 with acne and 34 who didn’t have the disease.
Growing up can be hard for any teenager without the added stress of acne. Sadly acne affects around 80% of adolescents aged 13-18 years at some point.
Acne develops due to an interplay between genetic factors (so people often have a family history) and hormonal factors that can increase the size and activity of the sebaceous or oil gland.
The mesoporous material Upsalite is shown to inhibit growth of bacteria associated with acne and hospital acquired infections.
Whether it’s from sudden trauma, scheduled surgery or serious acne, scarring can have a profound impact on patients.
The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older.
Novan, Inc. today announced that the first patient has been dosed in its Phase 3 program to evaluate the efficacy and safety of its topical nitric oxide product candidate SB204 Gel in the treatment of acne vulgaris (“acne”). The Company is running two identically designed Phase 3 pivotal trials in parallel and expects to report […]
Allergan plc, a leading global pharmaceutical company, today announced that the Company has received approval from the U.S. Food and Drug Administration to market ACZONE (dapsone) Gel, 7.5%, a new prescription topical treatment for acne in patients 12 years of age and older.
A medical records analysis by researchers at NYU Langone Medical Center concludes that physicians who treat severe acne leave too many patients on ineffective antibiotics for far too long before prescribing more potent needed therapy with the medication isotretinoin, sometimes known by its former brand name Accutane.